http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA05012635-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3e787a6871df4284213bb52de1883d |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C39-04 |
filingDate | 2005-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c8086d4dd5711403e2126b3fe0616b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3d176266b8483c01be26b32e37f4d85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_624b9f52805d7ecd4364653bba750254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d0510296dd6edc680d57b0bda926207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22a22038933ac50501d404ce877f85da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed393ac7bcde32c15f61a9a6019988c9 |
publicationDate | 2007-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | MX-PA05012635-A |
titleOfInvention | SYNTHESIS OF NEW METHYTIOMORPHOLINIC COMPOUNDS DERIVED FROM PHENOL FOR THE TREATMENT OF CARDIOVASCULAR DISEASES. |
abstract | The invention relates to the chemical synthesis, identification, determination of the chemical structure and the biological activity tests against cardiovascular diseases of organic compounds of methylthiomorpholinic derivatives of phenol, and of phenolic bis (methylthiomorpholin) compounds derived from phenol, specifically derived from 2 - (thiomorpholin-4-ylmethyl) phenol and its corresponding quaternary ammonium salts of formulas I, II, II, IV, and V, which behave as active agents for the treatment of cardiovascular diseases. The invention also relates to the preparation of pharmaceutical compositions and the use of phenol-derived methylthiomorpholinic compounds and phenol-derived bis (methylthiomorpholinin) compounds, specifically derivatives of 2- (thiomorpholin-4-ylmethyl) phenol and their corresponding quaternary ammonium salts of formulas I, II, II, IV and V, pharmaceutically acceptable for the manufacture of medicaments for the treatment of cardiovascular diseases. |
priorityDate | 2005-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.